New clinical-trial data suggest that an antiviral pill called ensitrelvir shortens the duration of two unpleasant symptoms of COVID-19: loss of smell and taste. The medication is among the first to alleviate these effects and, unlike other COVID-19 treatments, is not reserved only for people at high risk of severe illness.
Comments closedTag: research
HHS unveils $500 million more in ProjectNext Gen COVID funding, including for 3 vaccines
The US Department of Health and Human Services (HHS) today announced more than $500 million more in funding through its Project NextGen program to speed the development of new vaccines and treatments for COVID-19.
Comments closedNot ‘little adults’: Experts say long COVID undercounted, misdiagnosed in kids
Comments closedKids don’t come home and say, ‘Mom, I have postexertional malaise, I have brain fog.’ What happens is that they start doing poorly in school, and parents find out weeks and weeks later.
Covid-19 vaccines prevented 16,000 deaths in Ireland, study says
Ireland’s Covid-19 vaccination programme prevented 16,000 deaths and hugely reduced hospital and intensive care admissions, according to a Health Service Executive study.
Comments closedNew Zealand Covid response saved 20,000 lives, study says
Government’s strategy, which included closing the border, meant death rate was 80% lower than in the US, according to the New Zealand Medical Journal.
Comments closedVaccine Scientist Warns Antiscience Conspiracies Have Become a Deadly, Organized Movement
Vaccinologist Peter Hotez explains how the movement to oppose science and scientists has gained power.
Comments closedThis MacArthur ‘genius’ knew the initial theory of COVID transmission was flawed
The groundbreaking research of Linsey Marr, an aerosols expert and professor of civil and environmental engineering at Virginia Tech, showed that the SARS-CoV-2 virus is airborne as opposed to traveling in large droplets that fall with gravity.
Comments closedScientists behind mRNA COVID Vaccines Win 2023 Nobel Prize in Physiology or Medicine
This year’s Nobel Prize in Physiology or Medicine goes to a transformative medical technology that significantly altered the path of the pandemic and saved millions: the mRNA vaccines against COVID. Katalin Karikó and Drew Weissman were jointly awarded the prize for advancements that have changed the field of vaccine development and researchers’ understanding of how messenger RNA (mRNA) interacts with the body’s immune system.
Deux pionniers des vaccins à ARNm reçoivent le Nobel de médecine
On Monday, the Nobel Prize for Medicine recognized the work of Hungarian researcher Katalin Karikó and her American colleague Drew Weissman in the development of messenger RNA vaccines, decisive in the fight against COVID-19.
Comments closedSepsis associated with COVID-19 infections more common than thought
Today in JAMA Network Open, researchers provide new evidence that the prevalence of SARS-CoV-2–associated sepsis among hospitalized adults is higher than previously thought, but deaths from the condition became less frequent as the pandemic progressed.
Comments closedSARS-CoV-2 can infect coronary arteries and trigger heart attack, stroke, study suggests
SARS-CoV-2 can directly infect the arteries of the heart, inflaming the fatty plaque inside and raising the risk of heart attack and stroke, suggests a small study published yesterday in Nature Cardiovascular Research.
Comments closedSARS-CoV-2 infects coronary arteries, increases plaque inflammation
SARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health. The findings, published in the journal Nature Cardiovascular Research, may help explain why certain people who get COVID-19 have a greater chance of developing cardiovascular disease, or if they already have it, develop more heart-related complications.
Comments closedPeople with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Long COVID patients have clear differences in immune and hormone function from patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
The research, published in the September 25 issue of Nature, is the first to show specific blood biomarkers that can accurately identify patients with long COVID.
Comments closedLong Covid: MRI scans reveal new clues to symptoms
People living with long Covid after being admitted to hospital are more likely to show some damage to major organs, according to a new study.
MRI scans revealed patients were three times more likely to have some abnormalities in multiple organs such as the lungs, brain and kidneys.
Comments closedUp to 10 per cent of Quebec health-care workers affected with long COVID
Between six and 10 per cent of health-care workers in Quebec have suffered from long COVID since the start of the pandemic, preliminary data released on Thursday revealed at the first Canadian Symposium on long COVID, in Montreal.
Comments closedDoes the risk of getting long Covid increase each time you get reinfected?
More than three years into the coronavirus pandemic, fewer and fewer people are experiencing their first Covid-19 infections. But as cases climb, those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection?
Comments closedL’intestin des patients atteints de la COVID longue semble plus perméable
Individuals with the long COVID and neurological symptoms have different intestinal flora, it was heard on Wednesday at the first Canadian Symposium on Long COVID, held at the Hilton Midtown hotel in Montreal.
Comments closed1 in 4 COVID survivors had impaired lung function 1 year on, study shows
A quarter of COVID-19 survivors had impaired lung function 1 year after infection, and older patients, those with more than three chronic conditions, and those with severe cases improved slower than other patients over time, a Dutch study published yesterday in PLOS One reveals.
Comments closed